Faire progresser la recherche en cancérologie
IRIC - Institut de recherche en immunologie et en cancérologie (iric.ca) scores 73 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Education brands, in the 38th percentile of 21844 Healthcare brands.
IRIC (Institut de recherche en immunologie et en cancérologie) is a research institute affiliated with the Université de Montréal, founded in 2003 and based in Montreal, Canada. It focuses on advancing research in immunology and oncology to develop new cancer treatments, combining fundamental research with technological innovation such as computational pathology. Its audience includes researchers, scientists, students, academic and industry partners, and donors supporting cancer research.
| Brand Name | IRIC - Institut de recherche en immunologie et en cancérologie |
|---|---|
| Domain | iric.ca |
| Industry | Healthcare, Education |
| Founded | 2003 |
| Headquarters | Montreal, Canada |
| Parent Company / Owner | Université de Montréal |
| Main Competitors | Princess Margaret Cancer Centre, Ontario Institute for Cancer Research, BC Cancer, Institut Curie (80/100), Dana-Farber Cancer Institute (71/100), MD Anderson Cancer Center (83/100), Terry Fox Research Institute |
Ranked #538,306 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Faire progresser la recherche en immunologie et en cancérologie afin de développer de nouveaux traitements contre le cancer." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is FR-only, limiting citation in English-language AI answers.
Detected tech stack: Express, Nginx.
Social footprint: verified profiles on Facebook, YouTube, Instagram, X (Twitter), GitHub; no detected presence on LinkedIn - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked November 2026.
When asked "What is IRIC - Institut de recherche en immunologie et en cancérologie?", Claude could identify the brand as of November 2026. IRIC is a biomedical research institute affiliated with Université de Montréal, focused on fundamental and translational research in immunology and cancer biology, including genomics, proteomics, chemical biology, and drug discovery for leukemia and other cancers. Best known for Cutting-edge cancer and immunology research, particularly in leukemia stem cell biology and drug discovery, under the leadership of researchers like Guy Sauvage.
When asked "Best brands similar to IRIC - Institut de recherche en immunologie et en cancérologie?", Claude would recommend IRIC - Institut de recherche en immunologie et en cancérologie as of November 2026. It's a well-regarded academic research institute, so I'd mention it if someone asked about leading cancer/immunology research centers in Canada.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
IRIC - Institut de recherche en immunologie et en cancérologie's main competitors in Healthcare: Institut Curie (80/100), Dana-Farber Cancer Institute (71/100), MD Anderson Cancer Center (83/100).
Sources: Brand Analyzer scan
IRIC is a research institute affiliated with the Université de Montréal, founded in 2003 and located in Montreal, Canada. It is dedicated to advancing research in immunology and cancer biology with the goal of developing new cancer treatments.
Sources: IRIC - Institut de recherche en immunologie et en cancérologie official site
IRIC - Institut de recherche en immunologie et en cancérologie has low AI-search visibility, scoring 22/100 on Brand Analyzer's AI visibility composite (visibility 18, trust 4, recommendation 51). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: IRIC - Institut de recherche en immunologie et en cancérologie official site
IRIC - Institut de recherche en immunologie et en cancérologie was founded in 2003. IRIC - Institut de recherche en immunologie et en cancérologie operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
IRIC - Institut de recherche en immunologie et en cancérologie scores 51/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: IRIC - Institut de recherche en immunologie et en cancérologie official site
IRIC - Institut de recherche en immunologie et en cancérologie can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: IRIC - Institut de recherche en immunologie et en cancérologie official site
IRIC offers research services and infrastructure in immunology and cancerology, including fundamental scientific research and technological innovations like computational pathology aimed at developing new cancer treatments. It also provides research training opportunities for students and collaborates with academic and industry partners.
Sources: IRIC - Institut de recherche en immunologie et en cancérologie official site
IRIC is known for combining fundamental cancer and immunology research with technological innovation, such as computational pathology, to speed up the development of new cancer therapies, as part of its affiliation with the Université de Montréal.
Sources: IRIC - Institut de recherche en immunologie et en cancérologie official site
IRIC's work is used by researchers, scientists, and students conducting studies in immunology and cancer biology, as well as by academic and industrial partners collaborating on treatment development. Donors interested in supporting cancer research also engage with the institute.
Sources: IRIC - Institut de recherche en immunologie et en cancérologie official site
IRIC - Institut de recherche en immunologie et en cancérologie scores 22/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
IRIC - Institut de recherche en immunologie et en cancérologie has a weak AI-visibility profile at 22/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (51/100) and its weakest is trust (4/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #538,306 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify IRIC - Institut de recherche en immunologie et en cancérologie from memory (November 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to IRIC - Institut de recherche en immunologie et en cancérologie: Invest-NL (73/100), Invalidiliitto (73/100), Irish Life Health (73/100), International Society of Biomechanics (73/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.